Ascend Laboratories recalls

Ascend Laboratories has 50 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 5 Aug 2026. 28 are still ongoing. 13 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls50since 2016

Last 12 months13reported

Class I00% of total

Ongoing28latest 5 Aug 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 2 0 0Feb 0 0 0May 2 2 1Aug 1 4 0Nov 0 0 0Feb 0 0 1May 2 3 3Aug 0 0

Severity split

Class I 0 0%Class II 41 82%Class III 9 18%

Why ascend laboratories is recalled

Product types

Brands

By year

2026918%
20251020%
2024510%
2023918%
202224%
2021714%
202036%
201924%
201812%
201712%

Ongoing ascend laboratories recalls

28 active

Reported	Class	Recall	Company	Reason	Where
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 150 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 75 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 75 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS III	Dabigatran etexilate Capsules, 110 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recalledAmlodipine And Olmesartan Medoxomil	Ascend Laboratories	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS III	Dabigatran etexilate Capsules, 150 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide

All ascend laboratories recalls, newest first

50 total

Reported	Class	Recall	Company	Reason	Where
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 150 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 75 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
5 Aug 2026Drug	CLASS III	Dabigatran Etexilate Capsules, 75 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS III	Dabigatran etexilate Capsules, 110 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recalledAmlodipine And Olmesartan Medoxomil	Ascend Laboratories	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS III	Dabigatran etexilate Capsules, 150 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Potency & Assay	Nationwide
17 Jun 2026Drug	CLASS II	Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg recalledMinocycline Hydrochloride	Ascend Laboratories	Potency & Assay	Nationwide
10 Jun 2026Drug	CLASS II	Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg recalledAmlodipine And Olmesartan Medoxomil	Ascend Laboratories	Potency & Assay	Nationwide
20 May 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* recalledMetoprolol Succinate	Ascend Laboratories	Potency & Assay	Nationwide
22 Oct 2025Drug	CLASS II	Atorvastatin Calcium Tablets USP, 40 mg recalled by Ascend LaboratoriesAtorvastatin Calcium	Ascend Laboratories	Potency & Assay	Nationwide
22 Oct 2025Drug	CLASS II	Atorvastatin Calcium Tablets USP, 10 mg recalled by Ascend LaboratoriesAtorvastatin Calcium	Ascend Laboratories	Potency & Assay	Nationwide
22 Oct 2025Drug	CLASS II	Atorvastatin Calcium Tablets USP, 20 mg recalled by Ascend LaboratoriesAtorvastatin Calcium	Ascend Laboratories	Potency & Assay	Nationwide
22 Oct 2025Drug	CLASS II	Atorvastatin Calcium Tablets USP, 80 mg recalled by Ascend LaboratoriesAtorvastatin Calcium	Ascend Laboratories	Potency & Assay	Nationwide
24 Sep 2025Drug	CLASS II	Aripiprazole Tablets, USP, 10 mg recalled by Ascend LaboratoriesAripiprazole	Ascend Laboratories	Potency & Assay	Nationwide
20 Aug 2025Drug	CLASS II	Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg recalledAmlodipine And Olmesartan Medoxomil	Ascend Laboratories	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Rizatriptan Benzoate Tablets recalled by Ascend LaboratoriesRizatriptan Benzoate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
23 Jul 2025Drug	CLASS II	Rizatriptan Benzoate Tablets recalled by Ascend LaboratoriesRizatriptan Benzoate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
18 Jun 2025Drug	CLASS II	Cephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalledCephalexin	Ascend Laboratories	Potency & Assay	Nationwide
18 Jun 2025Drug	CLASS II	Cephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalledCephalexin	Ascend Laboratories	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Dabigatran Etexilate recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
18 Dec 2024Drug	CLASS II	Dabigatran Etexilate, 150mg capsules recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
2 Oct 2024Drug	CLASS II	Mycophenolic Acid Delayed-Release Tablets USP, 360 mg recalledMycophenolic Acid	Ascend Laboratories	Potency & Assay	Nationwide
28 Feb 2024Drug	CLASS II	Fosfomycin Tromethamine Granules for Oral Solution recalledFosfomycin Tromethamine	Ascend Laboratories	Potency & Assay	Nationwide
24 Jan 2024Drug	CLASS II	Ibuprofen and Famotidine Tablets 800mg/26.6mg recalledIbuprofen And Famotidine	Ascend Laboratories	Other	Nationwide
13 Sep 2023Drug	CLASS III	Fosfomycin Tromethamine Granules recalled by Ascend LaboratoriesFosfomycin Tromethamine	Ascend Laboratories	Potency & Assay	Nationwide
26 Jul 2023Drug	CLASS II	Fingolimod Capsules, 0.5 mg recalled by Ascend LaboratoriesFingolimod	Ascend Laboratories	Potency & Assay	Nationwide
26 Apr 2023Drug	CLASS II	Aripiprazole Tablets, USP, 20 mg recalled by Ascend LaboratoriesAripiprazole	Ascend Laboratories	Potency & Assay	Nationwide
5 Apr 2023Drug	CLASS II	Dabigatran Etexilate Capsules, 75 mg recalled by Ascend LaboratoriesDabigatran Etexilate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
5 Apr 2023Drug	CLASS II	Dabigatran Etexilate 150mg Capsules, 150 mg recalledDabigatran Etexilate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
1 Feb 2023Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, USP 50 mg recalledMetoprolol Succinate	Ascend Laboratories	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.